Fig. 1From: Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinomaPrediction of the efficacy of NPC patients treated with PD-1 inhibitors based on dynamic serum indicators. A Workflow for modeling and validation of prediction model; B LASSO regression analysis for candidates screening; C Coefficients of selected markers; D Unsupervised hierarchical clustering of selected markers and clinical outcomesBack to article page